Marinos C. Dalakas
Neuromuscular Diseases Section
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda
USA
Name/email consistency: high
- Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Dalakas, M.C., Rakocevic, G., Shatunov, A., Goldfarb, L., Raju, R., Salajegheh, M. Ann. Neurol. (2007)
- Advances in the immunobiology and treatment of inflammatory myopathies. Dalakas, M.C. Curr. Rheumatol. Rep (2007)
- Mechanisms of disease: signaling pathways and immunobiology of inflammatory myopathies. Dalakas, M.C. Nat. Clin. Pract. Rheumatol (2006)
- Inflammatory, immune, and viral aspects of inclusion-body myositis. Dalakas, M.C. Neurology (2006)
- The role of high-dose immune globulin intravenous in the treatment of dermatomyositis. Dalakas, M.C. Int. Immunopharmacol. (2006)
- Therapeutic targets in patients with inflammatory myopathies: present approaches and a look to the future. Dalakas, M.C. Neuromuscul. Disord. (2006)
- B cells in the pathophysiology of autoimmune neurological disorders: a credible therapeutic target. Dalakas, M.C. Pharmacol. Ther. (2006)
- Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies. Dalakas, M.C. Nature Clinical Practice. Neurology (2006)
- Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects. Dalakas, M.C. J. Neurol. (2006)
- Autoimmune muscular pathologies. Dalakas, M.C. Neurol. Sci. (2005)
- The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. Dalakas, M.C. J. Neurol. (2005)
- Intravenous immunoglobulin in patients with anti-GAD antibody-associated neurological diseases and patients with inflammatory myopathies: effects on clinicopathological features and immunoregulatory genes. Dalakas, M.C. Clin. Rev. Allergy. Immunol (2005)
- Intravenous immunoglobulin in autoimmune neuromuscular diseases. Dalakas, M.C. JAMA (2004)
- The molecular pathophysiology in inflammatory myopathies. Dalakas, M.C. Rev. Med. Interne (2004)
- The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Dalakas, M.C. Pharmacol. Ther. (2004)
- Update on the molecular pathogenesis of inflammatory myopathies. Dalakas, M.C. Autoimmun. Rev (2004)
- Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Dalakas, M.C. Curr. Opin. Neurol. (2004)
- Inhibiting leukocyte recruitment to the brain by IVIg: is it relevant to the treatment of demyelinating CNS disorders?. Dalakas, M.C. Brain (2004)
- Molecular pathogenesis of inflammatory myopathies and future therapeutic strategies. Dalakas, M.C. Suppl. Clin. Neurophysiol (2004)
- Stiff-person Syndrome. Vasconcelos, O.M., Dalakas, M.C. Curr. Treat. Options. Neurol (2003)
- Polymyositis and dermatomyositis. Dalakas, M.C., Hohlfeld, R. Lancet (2003)
- Muscle biopsy findings in inflammatory myopathies. Dalakas, M.C. Rheum. Dis. Clin. North Am. (2002)
- Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Dalakas, M.C., Li, M., Fujii, M., Jacobowitz, D.M. Neurology (2001)
- The molecular and cellular pathology of inflammatory muscle diseases. Dalakas, M.C. Curr. Opin. Pharmacol (2001)
- High-dose intravenous immune globulin for stiff-person syndrome. Dalakas, M.C., Fujii, M., Li, M., Lutfi, B., Kyhos, J., McElroy, B. N. Engl. J. Med. (2001)
